Series
Pulmonary and airways
Status
Published
Date
Number of report
095
Mechanical ventilation
Ask the expert
The report presents a summary of reimbursement situation for mechanical ventilation in European countries.
Sample pages are provided for an older version of the report. Before delivery to the client, the report is updated to the current state (e.g., 2022 coding, tariffs, and policy considerations).
The following clinical indications will be considered:
- Acute community-acquired viral pneumonia complicated with acute respiratory failure;
- Severe sepsis due to acute community-acquired viral pneumonia with multiorgan failure (cardiac, respiratory and renal);
- Acute hemorrhagic stroke with the development of coma.
The only reimbursement within public / statutory health insurance systems is considered.
Report includes essential information about reimbursement and national funding, including:
- Brief overview of reimbursement system for medical devices
- Procedure coding for technology
- Diagnosis coding
- Payment mechanism for technology
- Reimbursement tariffs for technology
- Restrictions in indications or scenarios for use of technology
- Policy considerations by payers and policy-makers about technology
Reimbursement information is provided for the following geographies:
- Austria
- Belgium
- Czech Republic
- Denmark
- England (UK)
- Finland
- France
- Germany
- Hungary
- Italy
- Netherlands
- Norway
- Romania
- Russia
- Sweden
- Switzerland
- Turkey
Manufacturers of devices for mechanical ventilation include:
- Air Liquide (Monnal, CPX Care, eXtend, Orion)
- Airon Mindray (E and SV Series)
- Allied Healthcare (EPV200)
- Breas Medical (Vivo)
- Dräger (Savina, Evita, Oxylog)
- Fisher & Paykel (F&P 850)
- FLU (FEILON) (VG70 Invasive Ventilator)
- GE Healthcare (CARESCAPE R860)
- Getinge (Servo-u, Servo-air, Servo-I, Servo-s)
- Hamilton Medical (HAMILTON-C1, HAMILTON-S1, HAMILTON-G5, HAMILTON-C3)
- Medtronic (Puritan Bennett, Newport)
- Philips Healthcare (Respironics BiPAP V30 Auto, Respironics V60, Respironics Trilogy 202, Respironics NM3, Respironics Respi-Link, Trilogy EV300)
- ResMed (Astral, Stellar, Lumis)
- Smiths Medical (PNEUPAC, PORTEX)
- Schiller (GRAPHNET, GRAPHNET ADVANCE, AQUILON)
- Teleflex (ConchaSmart, ISO-Gard, Comfort Flo)
- Vyaire Medical (Avea CVS, BELLAVISTA)
- WEINMANN (MEDUMAT)
- Zoll Medical (Z Vent)
Table of content is not available at the moment. Report is still ongoing.
08
Nov 2022
In October 2022, the National Institute for Health and Care Excellence (NICE) published two new Interventional Procedure Guidance (YAG laser vitreolysis for symptomatic vitreous floaters, transcutaneous electrical stimulation of the supraorbital nerve for treating and preventing migraine), one Medical Technologies Guidance (Magtrace and Sentimag system for locating sentinel lymph nodes for breast cancer) and three new Medtech Innovation Briefings (O2matic PRO 100, Daylight, Signatera). Also, one new clinical guideline was published on osteoarthritis.
Read more25
Oct 2022
On October 11, 2022, the Treatment Council (Behandlingsråd) announced the selection of two topics for major analyses (større analyser) for 2023, including the use of home non-invasive ventilation and the use of internet-based cognitive behavioral therapy.
Read more30
Sep 2022
Earlier this year, the CZ-DRG v5 was released in the Czech Republic by the Central Institute of Health Information and Statistics (ÚZIS). Currently, further changes are being implemented, and the CZ-DRG v5, revision 1, will be ready for implementation on January 1, 2023.
Read more27
May 2022
In April 2022, the National Institute for Health Research (NIHR) in England released two MedTech-related reports in its Health Technology Assessment (HTA) Journal, which concerned uterine artery embolization versus myomectomy for premenopausal women with uterine fibroids and supraglottic airway device versus tracheal intubation in the initial airway management. HTA Journal publishes research reports on the effectiveness, costs, and broader impact of health technologies for those who use, manage, and provide care in the NHS and informs National Institute for Health and Care Excellence (NICE) guidance.
Read more08
Oct 2021
In September 2021, the National Institute for Health and Care Excellence (NICE) published three new Interventional Procedure Guidance (transapical transcatheter mitral valve-in-valve implantation for a failed surgically implanted mitral valve bioprosthesis, transapical transcatheter mitral valve-in-ring (TMVIR) after failed annuloplasty for mitral valve repair, and lateral elbow resurfacing for arthritis), and two new Medtech Innovation Briefings (Carnation Ambulatory Monitor, OrganOx metra for liver transplant). Also, one clinical guideline was updated.
Read more